These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Deformable liposomes as enhancer of caffeine penetration through human skin in a Franz diffusion cell test. Abd E; Gomes J; Sales CC; Yousef S; Forouz F; Telaprolu KC; Roberts MS; Grice JE; Lopes PS; Leite-Silva VR; Andréo-Filho N Int J Cosmet Sci; 2021 Feb; 43(1):1-10. PubMed ID: 32866296 [TBL] [Abstract][Full Text] [Related]
9. Nanovesicular carrier-mediated transdermal delivery of tadalafil: i-formulation and physicsochemical characterization. Mehanna MM; Motawaa AM; Samaha MW Drug Dev Ind Pharm; 2015 May; 41(5):714-21. PubMed ID: 24669976 [TBL] [Abstract][Full Text] [Related]
10. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy. Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642 [TBL] [Abstract][Full Text] [Related]
11. Close-packed vesicles for diclofenac skin delivery and fibroblast targeting. Manca ML; Manconi M; Falchi AM; Castangia I; Valenti D; Lampis S; Fadda AM Colloids Surf B Biointerfaces; 2013 Nov; 111():609-17. PubMed ID: 23907049 [TBL] [Abstract][Full Text] [Related]
12. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy. Abdel-Hafez SM; Hathout RM; Sammour OA Colloids Surf B Biointerfaces; 2018 Jul; 167():63-72. PubMed ID: 29626721 [TBL] [Abstract][Full Text] [Related]
13. Penetration Enhancer-Containing Vesicles: Does the Penetration Enhancer Structure Affect Topical Drug Delivery? Caddeo C; Manconi M; Sinico C; Valenti D; Celia C; Monduzzi M; Fadda AM Curr Drug Targets; 2015; 16(13):1438-47. PubMed ID: 25090983 [TBL] [Abstract][Full Text] [Related]
14. Possibilities of the microemulsion use as indomethacin solubilizer and its effect on Špaglová M; Čuchorová M; Šimunková V; Matúšová D; Čierna M; Starýchová L; Bauerová K Drug Dev Ind Pharm; 2020 Sep; 46(9):1468-1476. PubMed ID: 32715801 [TBL] [Abstract][Full Text] [Related]
15. In Vivo Microdialysis for Dynamic Monitoring of the Effectiveness of Nano-liposomes as Vehicles for Topical Psoralen Application. Zhang H; Zhang K; Li Z; Zhao J; Zhang Y; Feng N Biol Pharm Bull; 2017; 40(11):1996-2000. PubMed ID: 29093350 [TBL] [Abstract][Full Text] [Related]
16. Skin Penetration and Permeation Properties of Transcutol®-Neat or Diluted Mixtures. Osborne DW; Musakhanian J AAPS PharmSciTech; 2018 Nov; 19(8):3512-3533. PubMed ID: 30421383 [TBL] [Abstract][Full Text] [Related]
17. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596 [TBL] [Abstract][Full Text] [Related]
18. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment. Garg BJ; Garg NK; Beg S; Singh B; Katare OP J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition. Kassem AA; Abd El-Alim SH; Asfour MH Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194 [TBL] [Abstract][Full Text] [Related]
20. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. Lowe NJ; Weingarten D; Bourget T; Moy LS J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]